NDC 69097-432 – Darifenacin
Darifenacin Hydrobromide 15 mg/1 · Tablet, Extended Release · Oral
Product NDC69097-432
Product details
- Brand name
- Darifenacin
- Generic name
- Darifenacin Hydrobromide
- Labeler
- Cipla USA Inc.
- Dosage form
- Tablet, Extended Release
- Route
- Oral
- Marketing category
- ANDA · ANDA207664
- Marketed since
- September 1, 2016
- Listing expires
- December 31, 2026
- Pharmacologic class
- Cholinergic Muscarinic Antagonist
Active ingredients
- Darifenacin Hydrobromide 15 mg/1
Package NDC codes (3)
| Package NDC | Description | Since |
|---|---|---|
| 69097-432-02 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (69097-432-02) | Sep 1, 2016 |
| 69097-432-05 | 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (69097-432-05) | Sep 1, 2016 |
| 69097-432-15 | 1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (69097-432-15) | Sep 1, 2016 |
Other Darifenacin products
- 62332-223 Darifenacin Hydrobromide 7.5 mg/1 · Tablet, Extended Release · Alembic Pharmaceuticals Inc.
- 62332-224 Darifenacin Hydrobromide 15 mg/1 · Tablet, Extended Release · Alembic Pharmaceuticals Inc.
- 46708-223 Darifenacin Hydrobromide 7.5 mg/1 · Tablet, Extended Release · Alembic Pharmaceuticals Limited
- 46708-224 Darifenacin Hydrobromide 15 mg/1 · Tablet, Extended Release · Alembic Pharmaceuticals Limited
- 72162-2570 Darifenacin Hydrobromide 7.5 mg/1 · Tablet, Extended Release · Bryant Ranch Prepack
- 72162-2571 Darifenacin Hydrobromide 15 mg/1 · Tablet, Extended Release · Bryant Ranch Prepack
- 69097-431 Darifenacin Hydrobromide 7.5 mg/1 · Tablet, Extended Release · Cipla USA Inc.
- 33342-276 Darifenacin Hydrobromide 7.5 mg/1 · Tablet, Extended Release · Macleods Pharmaceuticals Limited
- 33342-277 Darifenacin Hydrobromide 15 mg/1 · Tablet, Extended Release · Macleods Pharmaceuticals Limited
- 13668-202 Darifenacin Hydrobromide 7.5 mg/1 · Tablet, Extended Release · Torrent Pharmaceuticals Limited
- 13668-203 Darifenacin Hydrobromide 15 mg/1 · Tablet, Extended Release · Torrent Pharmaceuticals Limited
- 65862-861 Darifenacin Hydrobromide 7.5 mg/1 · Tablet, Film Coated, Extended Release · Aurobindo Pharma Limited